AKEBIA THERAPEUTICS, INC.

Profile

Company Names

AKEBIA THERAPEUTICS, INC.

Addresses

9987 CARVER ROAD, SUITE 420, CINCINNATI, OH 45242

Phone Numbers

513-985-1920

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$13,945,340.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-04-06 
$13,945,340.00 
$22,101,955.00 
$8,156,615.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANUPAM 
 
DALAL 
DIRECTOR
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NORA THERAPEUTICS, INC.   |  AERPIO PHARMACEUTICALS, INC.   |  ACUTA OPPORTUNITY FUND, LP   |  ACUTA CAPITAL FUND, LP   |  ACUTA OPPORTUNITY OFFSHORE FUND, LTD.   |  ACUTA CAPITAL OFFSHORE FUND, LTD.   |  AADI BIOSCIENCE, INC.
JOSEPH 
 
GARDNER 
EXECUTIVE OFFICER, DIRECTOR
AKEBIA THERAPEUTICS, INC.   |  AERPIO PHARMACEUTICALS, INC.
IAN 
 
HOWES 
EXECUTIVE OFFICER
AKEBIA THERAPEUTICS, INC.   |  INFUSION MEDICAL, INC.   |  MAGNOLIA NEUROSCIENCES CORP   |  RODEO THERAPEUTICS CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
KEVIN 
 
PETERS 
EXECUTIVE OFFICER
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  AVID GROUP, INC.
JOHN 
 
RICE 
DIRECTOR
JOHNSONDIVERSEY HOLDINGS INC   |  ALGAL SCIENTIFIC CORP   |  ESSENCE GROUP HOLDINGS CORP   |  AKEBIA THERAPEUTICS, INC.   |  RFG HOLDINGS, LLLP   |  AERPIO THERAPEUTICS, INC.   |  WALKER + DUNLOP, INC.   |  REASON TO BELIEVE, LLC   |  SUSTAIN LLC   |  VIRTUE LABS, LLC   |  ENABLE INJECTIONS, INC   |  AMGI HOLDINGS, INC.   |  SIGMA LABS, INC.   |  PRIME PROPERTY FUND, LLC   |  SURROUND CARE, LLC
ROBERT 
 
SHALWITZ 
EXECUTIVE OFFICER
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  INVIRSA, INC.
PAUL 
 
WEISS 
DIRECTOR
EUTHYMICS BIOSCIENCE INC   |  PIPELINE FINANCE LLC   |  AKEBIA THERAPEUTICS, INC.   |  GINNIE ACCEPTANCE COMPANY, LLC   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  WEST HILL STRATEGIC BOND FUND, LP   |  EUTHYMICS BIOSCIENCE, INC.   |  FLUGEN INC   |  INVENRA INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  TEN BAY BIO, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-04-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
2011-04-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#